Majedie Investments

The Barlow family owns approximately 50–54% of the trust's shares. William Barlow, a former CEO of the trust, sits on the board as a non-executive director representing the family's interests. Chairman Christopher Getley oversees the board independently of the family.

Majedie uses a flexible mandate that blends public equities, activist special situations, commodities, and private co-investments. Known positions include a uranium thesis via Cameco Corp, a copper ETF, UK gilts, and co-investments with Glenview Capital on a CVS Health activist campaign. The trust operates under the Association of Investment Companies' Flexible Investment sector classification.

It is structured as a publicly listed investment trust, not a private family office. However, the Barlow family's controlling stake—roughly 50–54%—gives it permanent capital characteristics. This hybrid structure allows the family to maintain generational control while accessing public markets for liquidity and transparency.

Yes. In the US, Majedie has partnered with Glenview Capital on Project Senior, an activist position in CVS Health. In Brazil, it works with HIX Capital on Project Vista. These co-investments allow the trust to access deals and campaigns alongside specialist managers.

The Barlow family's wealth is not tied to a single publicly disclosed operating company or liquidity event. The family's holding in Majedie Investments represents an enduring, multi-generational capital base managed through the listed trust structure.